This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Isenberg, D A Articles by Gordon, C Search for Related Content PubMed PubMed Citation Articles by Isenberg, D A Articles by Gordon, C Social Bookmarking                         What's this?

From BILAG to BLIPS—disease activity assessment in lupus past, present and future

Centre for Rheumatology, Department of Medicine, University College London, UK

C Gordon

Department of Rheumatology, University of Birmingham, Birmingham, UK

During the past 16 years, members of the British Isles Lupus Assessment Group (BILAG) have met on a regular basis and have been instrumental in devising a comprehensive disease activity index and, in association with others in the international rheumatological community, devising and/or testing damage and patients self-assessment indices. The history of what the BILAG group has achieved is set out here and the latest attempts at computerisation and improvements in the Disease Activity Index itself are described.

Key Words: BILAG • lupus damage index • lupus activity index

Lupus, Vol. 9, No. 9, 651-654 (2000)
DOI: 10.1191/096120300672904669


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				M. PETRI, S. SINGH, H. TESFASYONE, and A. MALIK Prevalence of Flare and Influence of Demographic and Serologic Factors on Flare Risk in Systemic Lupus Erythematosus: A Prospective Study J Rheumatol, November 1, 2009; 36(11): 2476 - 2480. [Abstract] [Full Text] [PDF]

				L. Cresswell, C.-S. Yee, V. Farewell, A. Rahman, L.-S. Teh, B. Griffiths, I. N. Bruce, Y. Ahmad, A. Prabu, M. Akil, et al. Numerical scoring for the Classic BILAG index Rheumatology, September 24, 2009; (2009) kep183v1. [Abstract] [Full Text] [PDF]

				A. Prabu, K. Patel, C.-S. Yee, P. Nightingale, R. D. Situnayake, D. R. Thickett, J. N. Townend, and C. Gordon Prevalence and risk factors for pulmonary arterial hypertension in patients with lupus Rheumatology, August 11, 2009; (2009) kep203v1. [Abstract] [Full Text] [PDF]

				C Gordon, G Bertsias, J P A Ioannidis, J Boletis, S Bombardieri, R Cervera, C Dostal, J Font, I-M Gilboe, F Houssiau, et al. EULAR points to consider for conducting clinical trials in systemic lupus erythematosus Ann Rheum Dis, April 1, 2009; 68(4): 470 - 476. [Abstract] [Full Text] [PDF]

				C Gordon, D Jayne, C Pusey, D Adu, Z Amoura, M Aringer, J Ballerin, R Cervera, J Calvo-Alen, C Chizzolini, et al. European consensus statement on the terminology used in the management of lupus glomerulonephritis Lupus, March 1, 2009; 18(3): 257 - 263. [Abstract] [PDF]

				C-S Yee, D A Isenberg, A Prabu, K Sokoll, L-S Teh, A Rahman, I N Bruce, B Griffiths, M Akil, N McHugh, et al. BILAG-2004 index captures systemic lupus erythematosus disease activity better than SLEDAI-2000 Ann Rheum Dis, June 1, 2008; 67(6): 873 - 876. [Abstract] [Full Text] [PDF]

				C. Gordon, D. J. Wallace, S. Shinada, K. C. Kalunian, L. Forbess, G. D. Braunstein, and M. H. Weisman Testosterone patches in the management of patients with mild/moderate systemic lupus erythematosus Rheumatology, March 1, 2008; 47(3): 334 - 338. [Abstract] [Full Text] [PDF]

				A. Sinclair, G. Appel, M.A. Dooley, E. Ginzler, D. Isenberg, D. Jayne, D. Wofsy, and N. Solomons Mycophenolate mofetil as induction and maintenance therapy for lupus nephritis: rationale and protocol for the randomized, controlled Aspreva Lupus Management Study (ALMS) Lupus, December 1, 2007; 16(12): 972 - 980. [Abstract] [PDF]

				M K Piper, K Raza, S L Nuttall, R Stevens, V Toescu, S Heaton, J Gardner-Medwin, L Hiller, U Martin, J Townend, et al. Impaired endothelial function in systemic lupus erythematosus Lupus, February 1, 2007; 16(2): 84 - 88. [Abstract] [PDF]

				D. A. Isenberg, A. Rahman, E. Allen, V. Farewell, M. Akil, I. N. Bruce, D. D'Cruz, B. Griffiths, M. Khamashta, P. Maddison, et al. BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosus Rheumatology, July 1, 2005; 44(7): 902 - 906. [Abstract] [Full Text] [PDF]

				C-S Yee, N Crabtree, J Skan, N Amft, S Bowman, D Situnayake, and C Gordon Prevalence and predictors of fragility fractures in systemic lupus erythematosus Ann Rheum Dis, January 1, 2005; 64(1): 111 - 113. [Abstract] [Full Text] [PDF]

				S. D. Marks, C. Pilkington, P. Woo, and M. J. Dillon The use of the British Isles Lupus Assessment Group (BILAG) index as a valid tool in assessing disease activity in childhood-onset systemic lupus erythematosus Rheumatology, September 1, 2004; 43(9): 1186 - 1189. [Abstract] [Full Text] [PDF]

				V Strand Clinical trial design in systemic lupus erythematosus: lessons learned and future directions Lupus, May 1, 2004; 13(5): 406 - 411. [Abstract] [PDF]

				C. Gordon, N. Sutcliffe, J. Skan, T. Stoll, and D. A. Isenberg Definition and treatment of lupus flares measured by the BILAG index Rheumatology, November 1, 2003; 42(11): 1372 - 1379. [Abstract] [Full Text] [PDF]

				C.-S. Yee, H. Hussein, J. Skan, S. Bowman, D. Situnayake, and C. Gordon Association of damage with autoantibody profile, age, race, sex and disease duration in systemic lupus erythematosus Rheumatology, February 1, 2003; 42(2): 276 - 279. [Abstract] [Full Text] [PDF]

				A Rahman and F Hiepe Anti-DNA antibodies - overview of assays and clinical correlations Lupus, December 1, 2002; 11(12): 770 - 773. [Abstract] [PDF]

				D Isenberg and R Smeenk Clinical laboratory assays for measuring anti-dsDNA antibodies. Where are we now? Lupus, December 1, 2002; 11(12): 797 - 800. [Abstract] [PDF]

				D A Isenberg and D Gladman The Systemic Lupus International Collaborating Clinics Group - origins and outcomes Lupus, May 1, 2001; 10(5): 375 - 377. [PDF]